Results 201 to 210 of about 60,411 (263)

Anti-inflammatory interventions for the treatment and prevention of depression among older adults: a systematic review and meta-analysis. [PDF]

Transl Psychiatry
Gong H, Su WJ, Deng SL, Luo J, Du ZL, Luo Y, Lv KY, Zhu DM, Fan XT.   +8 more
europepmc   +1 more source

Biotin Mitigates Alcohol Withdrawal-Induced Anxiety and Depression by Regulating Serotonin Metabolism, BDNF, Inflammation, and Oxidative Stress in Rats. [PDF]

Neuropsychopharmacol Rep
Hossaini D, Alipour AK, Sajjadi M, Ansari M, Haidary M.   +4 more
europepmc   +1 more source

Plant hormone jasmonic acid reduces anxiety behavior in mice. [PDF]

Sci Rep
Kanzaki H, Suzuki S, Tabata T, Suzuki T, Seto Y, Kaneko K.   +5 more
europepmc   +1 more source

Nature's Remedies: Exploring the Potential of Propolis to Alleviate Non-Motor Manifestations of Parkinson's Disease. [PDF]

Molecules
Matias KV, Gonçalves VC, Scorza FA, Finsterer J, Ciconelli RM, Scorza CA.   +5 more
europepmc   +1 more source

Pharmacology of oxazepam (Serax), a new anti-anxiety agent.

Current therapeutic research, clinical and experimental, 1966
openaire   +1 more source

Demographic Perspectives and De-escalation Challenges in Pediatric Emergency Care for Children with Special Health Care Needs.

J Emerg Trauma Shock
Rivera-Koberstein N, Agrawal A, Galwankar S.   +2 more
europepmc   +1 more source

Chapter 1. Antipsychotic and Anti-anxiety Agents

, 1966
Publisher Summary This chapter discusses various antipsychotic and anti-anxiety agents. Most of the compounds discussed in the chapter are tested by two general methods: (1) the study of animal behavior following drug treatment in experimental models designed to mimic a clinical situation (conflict, avoidance, etc.) and (2) the measurement of ...
Scott J. Childress
  +6 more sources

Chapter 1. Antipsychotic and Anti-anxiety Agents

, 1970
Publisher Summary This chapter discusses the results of studies focusing on antipsychotic and anti-anxiety agents. A double blind controlled study showed an approximately 10% better response in schizophrenic patients with droperidol than with haloperidol.
R. Ian Fryer
  +5 more sources